Crocs, Inc. (CROX) AI Stock Analysis

Crocs, Inc., along with its subsidiaries, designs, develops, manufactures, markets, and distributes casual lifestyle footwear and accessories for individuals of all ages. Established in 1999 and based in Broomfield, Colorado, its product portfolio features clogs, sandals, slides, flip-flops, boots, flats, wedges, platforms, loafers, sneakers, slippers, socks, and shoe charms under the Crocs brand name. The company distributes products across approximately 85 countries through wholesalers, company-operated retail and outlet stores, kiosks, third-party marketplaces, and e-commerce platforms.

Crocs expanded annual revenue from $2.31B in FY2021 to $4.10B in FY2024 before revenue declined 1.5% to $4.04B in FY2025. Between FY2020 and FY2025, revenue posted a 5-year CAGR of 23.9%. Net income shifted from $725.7M in FY2021 to -$81.2M in FY2025, when operating margin narrowed to 3.7%. For the trailing twelve months ending June 30, 2026, revenue stood at $4.05B, operating margin recovered to 24.2%, and profit margin reached 14.6%. In the latest quarter ended June 30, 2026, quarterly revenue rose 2.6% year-over-year while quarterly earnings declined 4.2%.

As of June 30, 2026, Crocs held $170.3M in cash and short-term investments against total debt of $1.69B, resulting in net debt of $1.52B. Shareholders' equity was $1.38B, yielding a debt-to-equity ratio of 1.22 and a current ratio of 1.49. In FY2025, the company generated $710.4M in operating cash flow and $659.2M in free cash flow. Capital expenditures were $51.2M, while share buybacks totaled $582.3M. The company's 5-year share count change was -16.6%.

Crocs has a market cap of $5.90B and an enterprise value of $7.42B. The stock trades at a trailing P/E of 10.8x and a forward P/E of 8.2x, below the median of its US-listed Consumer Cyclical peers of 18.0x trailing and 14.1x forward. Its EV to EBITDA stands at 8.0x compared to the peer median of 11.1x, while its price-to-sales of 1.5x is above the peer median of 0.7x. CROX returned 48.1% over the past year, outperforming the S&P 500 return of 16.8%, but its 5-year return of -10.2% trailed the index's 83.0% gain.

Wall Street coverage includes 5 Strong Buy, 3 Buy, 6 Hold, 0 Sell, and 1 Strong Sell recommendations. The mean price target is $138.75, which is 12.7% above the last close of $123.14. For the fiscal year ending December 31, 2026, analysts estimate EPS of $13.97, representing 11.6% growth, on revenue of $4.10B. For the following fiscal year, 15 analysts project EPS of $15.01 and revenue of $4.20B. Crocs beat EPS estimates in each of the last 4 quarters, with its next earnings date scheduled for October 29, 2026.

This page is an AI-written research summary of Crocs, Inc. (CROX). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: CROX income statement, CROX balance sheet, CROX key metrics, CROX analyst forecast, CROX chart. See the CROX stock overview for the latest quote and news.